Published in Eur J Drug Metab Pharmacokinet on September 21, 1989
Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients. Br J Clin Pharmacol (2003) 0.79
Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol (1983) 2.45
Nifedipine in hypertensive emergencies. Br Med J (Clin Res Ed) (1983) 1.75
Excretion and metabolism of 14C-midazolam in humans following oral dosing. Arzneimittelforschung (1981) 1.71
High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. Arch Intern Med (1991) 1.64
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans. Antimicrob Agents Chemother (1988) 1.64
Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bull World Health Organ (1982) 1.57
A new centrally action antihypertensive agent guanfacine (BS 100-141). Arzneimittelforschung (1977) 1.54
Characterization of the S locus genes, SLG and SRK, of the Brassica S3 haplotype: identification of a membrane-localized protein encoded by the S locus receptor kinase gene. Plant J (1995) 1.47
Quality of emergency room triage of medical inpatients to an acute care clinic or chronic health care facilities. J Gen Intern Med (1992) 1.40
Multiple biochemical blood testing as a case-finding tool in ambulatory medical patients. Am J Med (1993) 1.39
Usefulness of complete blood counts as a case-finding tool in medical outpatients. Ann Intern Med (1992) 1.37
Na K stimulated adenosinetriphosphatase: intracellular localisation within the proximal tubule of the rat nephron. Pflugers Arch (1971) 1.34
Identification and cloning of the chloroplast gene coding for the large subunit of ribulose-1,5-bisphosphate carboxylase from Chlamydomonas reinhardi. Proc Natl Acad Sci U S A (1977) 1.25
Expression of a self-incompatibility gene in a self-compatible line of Brassica oleracea. Plant Cell (1993) 1.24
Isolation of a homogeneous glucosidase II from pig kidney microsomes. Eur J Biochem (1984) 1.22
Activity of (Na+K+)-stimulated adenosintriphosphatase in the rat nephron. Pflugers Arch (1969) 1.21
Pollen-stigma adhesion in Brassica spp involves SLG and SLR1 glycoproteins. Plant Cell (1999) 1.12
Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med (1983) 1.11
Intranasal interferon (rIFN-alpha A, Ro 22-8181) for contact prophylaxis against common cold: a randomized, double-blind and placebo-controlled field study. Antiviral Res (1986) 1.10
Relation between regular intake of phenacetin-containing analgesics and laboratory evidence for urorenal disorders in a working female population of Switzerland. Lancet (1975) 1.07
RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia. Lancet (1985) 1.07
Single-dose kinetics of mefloquine in Brazilian male subjects. Bull World Health Organ (1987) 1.07
The effect of enzyme induction on diazepam metabolism in man. Br J Clin Pharmacol (1979) 1.05
Expression level of the SLG gene is not correlated with the self-incompatibility phenotype in the class II S haplotypes of Brassica oleracea. Plant Mol Biol (1995) 1.04
Sodium- and potassium-activated ATPase. A possible target of aldosterone. J Clin Invest (1975) 1.04
Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy. Klin Wochenschr (1969) 1.03
Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br J Clin Pharmacol (1983) 1.03
Effects of alpha- and beta-receptor blockade on systolic time intervals. Eur J Clin Pharmacol (1974) 1.03
Comparison of ribosomal proteins of chloroplast from spinach and of E. coli. Mol Gen Genet (1984) 1.02
Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol (1987) 1.02
The chloroplast genome of bleached mutants of Euglena gracilis. Biochim Biophys Acta (1981) 1.02
Relationships between regular analgesic intake and urorenal disorders in a working female population of Switzerland. I. Initial results (1968). Am J Epidemiol (1971) 1.01
Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrob Agents Chemother (1990) 1.01
Pharmacokinetics of carumonam in patients with renal insufficiency. Antimicrob Agents Chemother (1986) 1.01
Identification and Properties of the Messenger RNA Activity in Chlamydomonas reinhardi Coding for the Large Subunit of d-ribulose-1,5-bisphosphate Carboxylase. Plant Physiol (1977) 1.00
Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers. Antimicrob Agents Chemother (1989) 0.96
Distal tubular segments of the rabbit kidney after adaptation to altered Na- and K-intake. II. Changes in Na-K-ATPase activity. Cell Tissue Res (1982) 0.95
Sporophytic self-incompatibility systems: Brassica S gene family. Int Rev Cytol (1992) 0.95
Epidemiological study of analgesic intake and its relationship to urinary tract disorders in Switzerland. Helv Med Acta (1968) 0.95
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. Chemotherapy (1987) 0.95
[Influence of illumination on polysome formation in dark-grown Euglena gracilis cultures]. Biochim Biophys Acta (1972) 0.94
[The synthesis of ribosomal RNA during the illumination of dark-grown Euglena (author's transl)]. Biochim Biophys Acta (1974) 0.94
Uphill transport of pyrimidine nucleosides in renal brush border vesicles. Pflugers Arch (1985) 0.94
[Properties of Euglena gracilis ribosomes and ribosomal RNA]. Biochim Biophys Acta (1970) 0.93
Sodium gradient-energized concentrative transport of adenosine in renal brush border vesicles. Pflugers Arch (1984) 0.92
Pharmacokinetics of tenoxicam in healthy human volunteers. Eur J Rheumatol Inflamm (1984) 0.92
Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry (1979) 0.92
On the pharmacokinetics of phenacetin in man. Eur J Clin Pharmacol (1975) 0.91
Antihypertensive therapy with adrenergic beta-receptor blockers and vasodilators. Eur J Clin Pharmacol (1972) 0.91
Pharmacokinetic studies with chlorthalidone (Hygroton) in man. Eur J Clin Pharmacol (1977) 0.90
Peroxisomal and mitochondrial beta-oxidation in the rat kidney: distribution of fatty acyl-coenzyme A oxidase and 3-hydroxyacyl-coenzyme A dehydrogenase activities along the nephron. J Histochem Cytochem (1982) 0.89
On the origin of lactic dehydrogenase isoenzymes in urine. Helv Med Acta (1966) 0.89
Familial nephropathy and deafness: first observation of a family and close relatives in Switzerland. Helv Med Acta (1966) 0.89
Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects. Chemotherapy (1987) 0.89
The function of Na, K-ATPase in single portions of the rat nephron. Ann N Y Acad Sci (1974) 0.89
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects. Br J Clin Pharmacol (1997) 0.89
[Relation between the clinical effect and the pharmacokinetics of midazolam following i.m. and i.v. administration/2nd comm.: Pharmacokinetical aspects (author's transl)]. Arzneimittelforschung (1981) 0.89
[Absent renal ceramide-trihexosidase activity in Fabry's disease]. Ger Med Mon (1969) 0.88
Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase. Br J Clin Pharmacol (1999) 0.88
Concentrative transport of purine nucleosides in brush border vesicles of the rat kidney. Eur J Clin Invest (1985) 0.88
Effect of liver impairment on the pharmacokinetics of tolcapone and its metabolites. Clin Pharmacol Ther (1998) 0.88
[Urinary enzymes following medicamentous stimulation of the kidney using salicylate]. Schweiz Med Wochenschr (1967) 0.87
Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1989) 0.87
[Procedure on finding microhematuria in medical practice]. Schweiz Med Wochenschr (1975) 0.85
[Investigations into the action of xylitol on the stool flora (author's transl)]. Dtsch Med Wochenschr (1973) 0.85
Tissue printing and its applications in self-incompatibility studies. Plant Mol Biol (1993) 0.85
Kidney transplantation in Fabry's disease. Br Med J (1973) 0.84
[Effect of illumination on RNA synthesis and poly(adenylic acid) sequences in cultures of etiolated Euglena gracilis]. Biochim Biophys Acta (1973) 0.84
Renal metabolism of glucose: anatomical sites of hexokinase activity in the rat nephron. FEBS Lett (1975) 0.84
An ATP-inhibited soluble 5'-nucleotidase of rat kidney. Am J Physiol (1988) 0.84
[Different phenotypes of non-photosynthetic (photo-) phenotypes in Euglena gracilis: frequency of production by ultraviolet irradiation]. C R Seances Acad Sci III (1982) 0.83
Pharmacokinetics and pharmacodynamics after oral and intravenous administration of tolcapone, a novel adjunct to Parkinson's disease therapy. Eur J Clin Pharmacol (1998) 0.83
The cellular specificity of lectin binding in the kidney. I. A light microscopical study in the rat. Histochemistry (1982) 0.83
The activities of peroxisomal oxidases in periportal and perivenous zones of the rat liver acinus. Histochemistry (1980) 0.82
Acute renal failure after folate: NaK ATPase in isolated rat renal tubule. Ultramicrochemical and clinical studies. Eur J Clin Invest (1973) 0.82
Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. J Vet Pharmacol Ther (1991) 0.82
[Adrenal cortex and gonadal function in HIV infected patients]. Wien Med Wochenschr (1991) 0.82
Differential enzymatic behaviour of single proximal segments of the superficial and juxtamedullary nephron. I. Alkaline phosphatase, (Mg++) ATPase and Na+K+) ATPase. Z Gesamte Exp Med (1969) 0.82
[Does closely monitored control and therapy adjustment improve the prognosis in patients with severe heart insufficiency?]. Schweiz Med Wochenschr (1985) 0.81
Sensitivity of Na K adenosine triphosphatase activity in various structures of the rat nephron: studies with adrenalectomy. Eur J Clin Invest (1971) 0.81
Isolation and microinjection of active sperm nuclei into egg cells and central cells of isolated maize embryo sacs. Zygote (1994) 0.81
Purification and properties of a 5'-nucleotidase from rat renal membranes. Enzyme (1989) 0.81
Structure and variability of nuclear ribosomal genes in the genus Helianthus. Theor Appl Genet (1988) 0.81
[Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)]. Schweiz Rundsch Med Prax (1975) 0.81
[Urorenal diseases following regular intake of phenacetin containing analgesics]. Dtsch Med Wochenschr (1971) 0.81
Determination of the antimalarial mefloquine in human plasma by gas chromatography with electron-capture detection. J Chromatogr (1984) 0.80
[Extragenital endometriosis. Report of a case of pulmonary endometriosis]. Schweiz Med Wochenschr (1971) 0.80
Effect of probenecid on the elimination and protein binding of ceftriaxone. Eur J Clin Pharmacol (1988) 0.80
Carbohydrate metabolism in rat kidney: heterogeneous distribution of glycolytic and gluconeogenic key enzymes. Curr Probl Clin Biochem (1978) 0.80
Haemodynamic effects, plasma concentrations and tolerance of orally administered prenalterol in man. Eur J Clin Pharmacol (1980) 0.80
[New aspects on the question of phenacetin nephrotoxicity]. Experientia (1969) 0.80
Acute renal failure in the rat after folate intoxication: diagnostic value of lactate dehydrogenase and alkaline phosphatase measurements in serum and urine. Clin Nephrol (1974) 0.80
[Relationship between regular consumption of phenacetin analgesics and kidney damage. Prospective epidemiological study in Switzerland, 1968-72]. Schweiz Med Wochenschr (1974) 0.79
Evidence for orthologous S-locus-related I genes in several genera of Brassicaceae. Mol Gen Genet (2001) 0.79
Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors. Am Heart J (1978) 0.79
Properties of an ecto-5'-nucleotidase of the renal brush border. Ren Physiol (1985) 0.79
Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol and its metabolite Ro 3-7410 in hypertensive patients. Eur J Clin Pharmacol (1983) 0.79
[Sensitization to phenacetin: immunological aspects]. Dtsch Med Wochenschr (1973) 0.79